These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35068391)

  • 1. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis.
    Rinaldi I; Sutandyo N; Winston K
    Hematology; 2022 Dec; 27(1):141-149. PubMed ID: 35068391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
    Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
    Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
    Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
    Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol.
    Zeller B; Arad-Cohen N; Cheuk D; De Moerloose B; Navarro JMF; Hasle H; Jahnukainen K; Juul-Dam KL; Kaspers G; Kovalova Z; Jonsson OG; Lausen B; Munthe-Kaas M; Nystrom UN; Palle J; Pasauliene R; Pronk CJ; Saks K; Tierens A; Abrahamsson J
    Haematologica; 2024 Sep; 109(9):2873-2883. PubMed ID: 38721737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
    Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
    Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
    Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
    Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
    J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
    Malkan UY; Ozcebe OI
    Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of therapeutic leukapheresis in hyperleukocytotic AML.
    Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
    PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
    Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
    J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperleukocytosis in acute myeloid leukemia patients is associated with high 30-day mortality which is not improved with leukapheresis.
    Wong GC
    Ann Hematol; 2015 Dec; 94(12):2067-8. PubMed ID: 26255280
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter study.
    Zhang X; Tu Y; Shen J; Feng Y; Ma H; Bai L; Li X; Lin Z; Dai L; Gong F; Lu T; Zhou J; Chen H; Lv Q; Zhu Z; Ruan C
    Leuk Lymphoma; 2022 Nov; 63(11):2636-2644. PubMed ID: 35731036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia.
    Cuttner J; Holland JF; Norton L; Ambinder E; Button G; Meyer RJ
    Med Pediatr Oncol; 1983; 11(2):76-8. PubMed ID: 6572782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.